Opinion
Video
Author(s):
Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
Stay up to date on cancer updates, research and education
Therapies Which Received FDA Approval in July: What Patients Should Know
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
June Blood Cancer Highlights: Top 5 Updates Patients Should Know
The Treatment Journey of a Patient with CLL
FDA Approves Brukinsa Tablet For Various Blood Cancers
Zilovertamab Vedotin Plus Chemo Combo Shows Responses in R/R DLBCL